Literature DB >> 26817845

Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.

Cyril X George1, Gokul Ramaswami2, Jin Billy Li2, Charles E Samuel3.   

Abstract

Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2α at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-) (p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RNA editing; adenosine deaminase acting on RNA (ADAR); innate immunity; interferon; protein kinase RNA-activated (PKR); stress granule

Mesh:

Substances:

Year:  2016        PMID: 26817845      PMCID: PMC4813567          DOI: 10.1074/jbc.M115.709014

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  An unwinding activity that covalently modifies its double-stranded RNA substrate.

Authors:  B L Bass; H Weintraub
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

2.  Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase.

Authors:  Y Liu; C E Samuel
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase.

Authors:  C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

4.  Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes.

Authors:  K L Kuhen; C E Samuel
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

5.  Mechanism of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase.

Authors:  D C Thomis; C E Samuel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons.

Authors:  J B Patterson; D C Thomis; S L Hans; C E Samuel
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

7.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

8.  Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1.

Authors:  Jochen C Hartner; Carolin Schmittwolf; Andreas Kispert; Albrecht M Müller; Miyoko Higuchi; Peter H Seeburg
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

9.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase.

Authors:  J B Patterson; C E Samuel
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  55 in total

1.  TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes.

Authors:  Thomas J LaRocca; Andrea Mariani; Linda R Watkins; Christopher D Link
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 2.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

3.  Restricting retrotransposons: ADAR1 is another guardian of the human genome.

Authors:  Elisa Orecchini; Loredana Frassinelli; Alessandro Michienzi
Journal:  RNA Biol       Date:  2017-07-21       Impact factor: 4.652

Review 4.  Translation inhibition and stress granules in the antiviral immune response.

Authors:  Craig McCormick; Denys A Khaperskyy
Journal:  Nat Rev Immunol       Date:  2017-06-26       Impact factor: 53.106

Review 5.  Discrimination of Self and Non-Self Ribonucleic Acids.

Authors:  Anna Gebhardt; Beatrice T Laudenbach; Andreas Pichlmair
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

Review 6.  The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA.

Authors:  Jacki E Heraud-Farlow; Carl R Walkley
Journal:  J Mol Med (Berl)       Date:  2016-04-05       Impact factor: 4.599

Review 7.  A-to-I RNA editing - thinking beyond the single nucleotide.

Authors:  Nabeel S Ganem; Ayelet T Lamm
Journal:  RNA Biol       Date:  2017-10-11       Impact factor: 4.652

Review 8.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

Review 9.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

10.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.